MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Prospective Tractography-Guided STN DBS Targeting with Optimized vmPFC Connectivity for Apathy in PD a Case Report

    J. de Bruin, K S. Choi, J. Jimenez-Shahed, B. Kopell, H. Mayberg, M. Figee (New York, USA)

    Objective: Prospective tractography-guided DBS targeting of the left STN-vmPFC and primary motor pathway to improve apathy alongside motor symptoms in PD. Background: While STN DBS…
  • 2025 International Congress

    Uncovering the heterogeneity of spatiotemporal trajectories of neurodegeneration in Parkinson’s disease: an early-phase 18F-FP-CIT PET study

    SJ. Chung, J. Lee, Y. Choi, J. Jang, HK. Na, PH. Lee (Seoul, Republic of Korea)

    Objective: To define the subtypes of Parkinson’s disease (PD) based on the spatiotemporal progression patterns of cerebral hypoperfusion. Background: Early-phase 18F-FP-CIT PET images, which are…
  • 2025 International Congress

    Using Multi-Generational High-Risk Pedigrees to Identify Candidate Parkinson’s Disease Predisposition Genes

    P. Moretti, K. Allen-Brady, J. Stevens, K. Figueroa, S. Pulst, L. Cannon-Albright (Salt Lake City, USA)

    Objective: To identify rare genetic variants associated with increased risk of Parkinson’s disease (PD) in multi-generational, high-risk pedigrees. Background: Our current knowledge of PD genetics…
  • 2025 International Congress

    Does COMT Play a Role in Parkinson’s Disease Susceptibility Across Diverse Ancestral Populations?

    M. Martin-Bórnez, N. Shar, M. Nour, D. Murphy, I. Elsayed, M. Shri, F. Nwaokorie, A. Olusanya, N. Kuznetsov, S. Bandres-Ciga, A. Noyce, H. Iwaki, L. Jones, P. Gómez-Garre, P. Mir, MT. Periñan (Sevilla, Spain)

    Objective: To investigate the relationship between COMT genetic variants and PD risk across diverse ancestries. Background: The enzyme catechol-O-methyltransferase (COMT; OMIM:116790) plays a crucial role…
  • 2025 International Congress

    Interplay of GBA1 mutations and sex on determining depressive symptoms in Parkinson’s Disease

    M. Avenali, P. Mitrotti, CA. Artusi, R. de Micco, G. Giannini, S. Caminiti, C. Ledda, L. Gallo, C. Galandra, A. Mascia, M. Siciliano, F. Pagliuca, L. Sambati, V. Sant'Elia, G. Vornetti, G. Calandra-Buonaura, L. Lopiano, R. Lodi, A. Tessitore, M. Bozzali, EM. Valente (Turin, Italy)

    Objective: To study the interaction between GBA1 mutations, sex and other clinical factors in shaping depression outcomes in Parkinson’s Disease. Background: Depression affects 35% of…
  • 2025 International Congress

    Studying the Influence of Genetic Variations on Functional Performance in Parkinson’s Disease

    D. Moss, K. Smaller, M. Rafferty, P. Gonzalez-Latapi (Chicago, USA)

    Objective: To evaluate whether individuals with one of the seven most common genetic variants associated with Parkinson’s Disease (PD) exhibit differences in physical function performance…
  • 2025 International Congress

    Revealing Novel Genetic Contributors to Parkinson’s Disease in a Chinese Cohort: An Elaborate Examination within the CPD10KGP

    Z. Liu, Y. Zhao, H. Pan, B. Tang (Changsha, China)

    Objective: This study employs next-generation sequencing (NGS) and long-read sequencing data (LRS) in Chinese AR-PD families to uncover novel genes, enhancing our genetic comprehension of PD. Background:…
  • 2025 International Congress

    Efficacy and Safety of Fecal Microbiota Transplantation in the Management of Parkinson’s Disease: A Systematic Review

    Y. Abdalla, A. Hassan (Zagazig, Egypt)

    Objective: 1. Assess the efficacy of FMT in PD by evaluating its impact on motor and non-motor symptoms.2. Determine the safety profile of FMT in…
  • 2025 International Congress

    DBS Programming in Early Simultaneous STN-GPi Implantation for Young-Onset Parkinson’s: A Mini Case Series

    P. Kahali, V. Tanoury, J. Ng, M. Ferris (Palo Alto, USA)

    Objective: We aim to present our institution's experience with simultaneous dual STN-GPi implantation in Parkinson’s disease (PD) by analyzing a case series of 3 patients.…
  • 2025 International Congress

    Preoperative Predictors of Post-DBS Cognitive Decline: Cardiac MIBG Imaging and Levodopa Burden as Risk Factors for Dementia in Parkinson’s Disease

    DG. Park, YS. Kim, MS. Kim, JH. Yoon (Suwon, Republic of Korea)

    Objective: To identify preoperative clinical and imaging predictors of post-deep brain stimulation (DBS) dementia in Parkinson's disease (PD) patients, focusing on multiple potential risk factors…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley